Literature DB >> 24509353

[Types and management of perforations occurring during endoscopic retrograde cholangiopancreatography].

Zoltán Völgyi1, Mária Szenes1, Beáta Gasztonyi2.   

Abstract

The authors discuss the incidence of perforation related to endoscopic retrograde cholangio-pancreatography, which is relatively uncommon (0.3-1%) among other types of complications. Perforations can be classified into three types based on their forms and locations. Having reviewed the literature the authors conclude that the most common type is periampullary perforation and the less frequent one is peritoneal perforation. The former usually heals after conservative treatment, while the latter needs an operation. The authors emphasize the important prognostic role of timely diagnosis and surgical treatment if alarming signs (peritoneal, septic) are present. Known predisposing factors, when the procedure needs more careful attention, are also summarized (postoperative status, needle knife papillectomy, intramural contrast media, long lasting examination). After reviewing their own cases, the authors establish that the incidence of perforation in their own centre was four per thousand (10/2400), out of which nine were periampullar and one peritoneal type. In 6 cases operation was necessary, and there was no mortality. The authors conclude that individually tailored therapy can largely reduce the 30-40% mortality rate reported in earlier studies.

Keywords:  ERCP; complications; perforation; perforáció; szövődmények

Mesh:

Year:  2014        PMID: 24509353     DOI: 10.1556/OH.2014.29829

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  2 in total

Review 1.  Endoscopic management of perforations, leaks and fistulas.

Authors:  Ritu Raj Singh; Jeremy S Nussbaum; Nikhil A Kumta
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-31

2.  Endoscopic Closure for EUS and ERCP Related Duodenal Perforation by Endoclips.

Authors:  Yaping Liu; Dong Wang; Zhaoshen Li
Journal:  Gastroenterol Res Pract       Date:  2016-09-15       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.